@jokesten.bsky.social
"It really can take 17 years to move evidence into practice" Mindblowing facts in keynote from Prof @felixnaughton.bsky.social #uksbm25
📢 New preprint. Our study develops the PATH-GP intervention to increase #HIV testing & #PrEP access in general practice. Study led by @sarahdenford.bsky.social @jokesten.bsky.social Read the full article here: www.medrxiv.org/content/10.1... 🛟 #HIVsky #GUMsky #STIsky
Developing the PATH-GP (Prevention and Testing for HIV in General Practice) intervention: a Person-Based Approach intervention development study to increase HIV testing and PrEP access.
Background Testing for HIV, linkage to treatment and access to pre-exposure prophylaxis (PrEP) (medication which reduces the risk of acquiring HIV) is essential for early HIV diagnosis, treatment, and...
medrxiv.org
New paper reporting 6 co-use patterns & scope for harm reduction: (1) co-use to aid sleep or come down (2) curated co-use (3) morning and evening benzodiazepine doses with opioids throughout the day (4) co-use binges (5) co-use throughout the day (6) benzodiazepine use throughout the day plus OAT